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ABSTRACT
DataBase of Transcription Start Sites (DBTSS) is
a database which contains precise positional
information for transcription start sites (TSSs)
of eukaryotic mRNAs. In this update, we included
330 million new tags generated by massively
sequencing the 50-end of oligo-cap selected
cDNAs in humans and mice. The tags were collected
from normal fetal or adult human tissues, including
brain, thymus, liver, kidney and heart, from 6 human
cell lines in 21 diverse growth conditions as well as
from mouse NIH3T3 cell line: altogether 31 different
cell types or culture conditions are represented.
This unprecedented increase in depth of data now
allows DBTSS to faithfully represent the dynamically
changing landscape of TSSs in different cell types
and conditions, during development and in the
course of evolution. Differential usage of alternative
50-ends across cell types and conditions can be
viewed in a series of new interfaces. Promoter
sequence information is now displayed in a compar-
ative genomics viewer where evolutionary turnover
of the TSSs can be evaluated. DBTSS can be
accessed at http://dbtss.hgc.jp/.
INTRODUCTION
Precise positional information on the transcription start
sites (TSSs) and their expression levels are key for iden-
tifying the putative upstream promoter regions and under-
standing transcriptional regulation of the genes. For this
purpose, we have constructed DBTSS, a DataBase of
Transcription Start Sites (1). DBTSS is based on our
unique data which are experimentally validated by 50-end-
sequencing of full-length cDNA libraries constructed
using our oligo-capping method (2). Recently, in order
to facilitate the data collection, we developed a new
method, which we named TSS Seq (3). This method
combines the oligo-capping and the massively parallel
sequencing technology (4), so that tens of millions of
TSSs data can be generated from a single assay.
In the previous update, we have published 20million
transcription start tag data collected from human MCF7
(Human breast adenocarcinoma) and HEK293 (Human
embryonic kidney) cells (1). A similar approach using
the deep CAGE method (5) on human THP1 (Human
acute monocytic leukemia) cells lead the RIKEN
FANTOM4 consortium to add 6million 50-end tags to
their database (6). Through in-depth analysis of the
TSSs in particular cell types, it has become gradually
clear that a large number of human genes contain
multiple (alternative) promoters (7,8) and each mamma-
lian cell seems to utilize its own set of promoters (9).
Therefore, a simple catalogue of the promoters, as often
provided in the pre-existing databases, cannot represent a
global view of transcriptional regulation in human genes,
which is highly diversiﬁed and changes dynamically
depending on cellular circumstances. For this purpose, it
is essential to collect TSS data from a wider collection of
cell types in diverse cellular environments. An appropriate
interface is also indispensable to represent the TSS col-
lected from diﬀerent data points in an integrative
manner. In this update, DBTSS includes about
300million TSS tags collected from 31 diﬀerent TSS Seq
libraries, each of which contains  10million TSS tags.
The TSS data sets from each of the TSS Seq libraries
were interconnected in our new interface, so that users
can empirically understand the diﬀerential usage of the
promoters. Here, we describe the update of our DBTSS,
which enables, for the ﬁrst time, to illustrate the dynamic
nature of the mammalian gene promoters.
NEW FEATURES
Statistics of the newly included TSS data
In this update, we have included a total of 330533354 new
36-bp-single-end-read TSS tags. These tags were collected
from a series of oligp-capped libraries constructed from
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fetal brain, fetal kidney, fetal heart, fetal thymus and fetal
liver) and six cultured cell lines (colon cancer DLD1, B
lymphocyte Ramos, bronchial epithelial cells BEAS2B,
embryonic kidney HEK293, breast adenocarcinoma
MCF7 and fetal lung TIG3 in humans) and ﬁbroblast
NIH3T3 cells in mice; for details on the origin of the
cells, see http://dbtss.hgc.jp/cgi-bin/cell_type.cgi. We con-
structed the 50-end libraries using six cell types cultured in
diﬀerent conditions, such as hypoxia or normoxia,
and with or without IL4 treatment. Altogether, the
current DBTSS includes 31 diﬀerent cell types or culture
conditions, each containing  10million TSS tags
(Table 1). Accession numbers for each dataset are given
in http://dbtss.hgc.jp/cgi-bin/accession.cgi. Details of the
experimental procedures are also described in http://dbtss
.hgc.jp/docs/protocol_solexa.html.
The TSS tags in every dataset were clustered into
500bp-bins to separate transcription start clusters
(TSCs), each of which may represent independent
promoters [also see Ref. (3) for further details]. 50-end
clusters were further split according to whether they
mapped in the vicinity of a RefSeq gene (from  50Kb
upstream from the 50-end of a RefSeq transcript to the
30-end of it) or further than 50Kb away, in what we call
an intergenic region. As summarized in Table 1, on
average, there were  100000 RefSeq transcription start
clusters and 40000 intergenic ones per cell and per
culture condition. In spite of the generally large number
of 50-end clusters consistent with previous observations
from ourselves (3) and others (5), most of the clusters
were composed of one or two TSSs. The TSCs having
signiﬁcant expression levels, which may be prioritized for
further biological functional characterizations, were rela-
tively rare. The number of TSCs having expression levels
of >5ppm (part per million tags; note that 1ppm
corresponds to 1 copy per cell, assuming every cell
contains 1million mRNA copies) is summarized in
Table 1. Detailed statistics on every TSS Seq sub-dataset
are shown in http://dbtss.hgc.jp/cgi-bin/cell_type.c.
All data can be downloaded on our download site
(ftp://ftp.hgc.jp/pub/hgc/db/dbtss/dbtss_ver7/).
Table 1. Statistics of the new TSS Seq data
Panel A
Sample name Cell type Condition Time course Tag count
DLD1 (Hypoxia with non-tagged RNAi) Fibroblast 1% O2 24h 7723359
DLD1 (Hypoxia with HIF1A RNAi) Fibroblast 1% O2 24h 7727105
DLD1 (Normoxia with HIF1A RNAi) Fibroblast 21% O2 24h 7410902
DLD1 (Hypoxia with HIF2A RNAi) Fibroblast 1% O2 24h 8737554
DLD1 (Normoxia with non-targetedRNAi) Fibroblast 21% O2 24h 8644835
DLD1 (Normoxia with HIF2A RNAi) Fibroblast 21% O2 24h 8353702
Beas2B overexpress STAT6 IL4+ Bcell IL4 4h 22954017
Beas2B overexpress STAT6 IL4  Bcell 21127774
Beas2B parent IL4+ Bcell IL4 4h 15166848
Beas2B parent IL4  Bcell 11628747
Beas2B stat6 siRNA  IL4+ Bcell IL4 4h 8243100
Beas2B stat6 siRNA  IL4  Bcell 7857509
Beas2B stat6 siRNA+IL4+ Bcell IL4 4h 5879777
Beas2B stat6 siRNA+IL4  Bcell 5931745
Ramos IL4+ Bcell IL4 4h 15268493
Ramos IL4  Bcell 15759413
MCF7 O2 1% Breast adenocarcinoma 1% O2 24h 7531326
MCF7 O2 21% Breast adenocarcinoma 21% O2 24h 13609932
TIG O2 1% Fetal lung 1% O2 24h 8848737
TIG O2 21% Fetal lung 21% O2 24h 9235808
293 O2 1% Embryonic kidney 1% O2 24h 10590128
293 O2 21% Embryonic kidney 21% O2 24h 8162101
Fetal Heart Normal fetal tissues 10182282
Fetal Kidney Normal fetal tissues 8424482
Fetal Liver Normal fetal tissues 4741889
Fetal Thymus Normal fetal tissues 7122556
Fetal Brain Normal fetal tissues 11285710
Brain Normal adult tissues 11561960
Heart Normal adult tissues 9378901
Kidney Normal adult tissues 11196359
Mouse 3T3 Fibroblast 20246303
Total 330533354
Panel: B
Average 50-end
clusters per cell
Average number of
TSCs>5ppm per cell
Number of represented genes
(coverage against total RefSeq genes)
RefSeq region 105134 6972 17879/18001 (99%)
Intergenic region 40537 1083 ND
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As the expanded DBTSS data contains hundreds of
millions of TSS data collected from dozens of diﬀerent
cell types in diverse culture conditions, it is essential to
represent the TSS data to meet the users’ interests.
Otherwise, the database becomes no more than a
confusing compilation of massive TSS data. First, we
masked the clusters with very low expression levels
(<5ppm at the default setting, although there is an
option to show all the TSSs), considering they might be
derived from intrinsic transcriptional noise of the cells (10)
or other experimental errors. Second, we categorized the
TSCs in a series of the TSS Seq data so that users can
empirically understand the diﬀerential usage of the TSSs
in diﬀerent cell types or culture conditions. For graphical
representation, we developed a series of new interfaces as
shown in Figures 1 and 2. The TSSs corresponding to a
particular gene of interest to the user (Figure 1B) can be
retrieved and their diﬀerential usage in diﬀerent cellular
circumstances can be represented. Figure 1D exempliﬁes
the tissue-speciﬁc alternative promoter. In the zinc ﬁnger
protein 622 gene (NM_033414), the second upstream
alternative promoter (moss green) was selectively used
in fetal heart, while a diﬀerent alternative promoter
(light green) is used in the other tissues including adult.
Also, using our new search page as shown in Figure 1C,
users can search promoters showing signiﬁcant expression
changes in response to particular environmental changes.
Figure 1. Interfaces of the newly implemented ‘TSS tag viewer’. TSS sequence tag information can be retrieved from the top page (A) by following
either of the links. The viewers corresponding to each link are represented in the indicated ﬁgures. (B) In the ‘Database Search’ form, users can
directly specify the 50-end tags of a gene or a cell type they want to view. (C) In the ‘TSS tag search’ form, users can search TSS tags by specifying
cell types, fold induction and/or tag counts. They can also choose which category of tags should be considered (e.g. whether tags of diﬀerent
alternative promoters should be counted separately or not). (D) An example of developmental stage-speciﬁc alternative promoters. In the zinc ﬁnger
protein 622 gene (NM_033414), the promoter indicated in moss green (second panel) is selectively used in fetal heart. The upper and lower
panels represent the TSS tag usages in adult and fetal tissues, respectively. Height of the vertical bars represents the number of TSS Seq tags
located in the corresponding genomic regions. Diﬀerent alternative promoters are represented by diﬀerent colors. Each horizontal line represents
the experimental condition from which TSS tags were derived. Legends for the tissues and sum of the TSS tag counts are shown at the right margin.
(E) Example of the case in which alternative promoter-speciﬁc induction was observed in response to IL-4 stimulation in Ramos cells. In the
hypothetical protein LOC746 gene (NM_ 014206), the alternative promoter indicated in red (ﬁrst panel) is selectively induced while the other
alternative promoter indicated in blue (second panel) remained unchanged. The indicated TSS regions are magniﬁed to the nucleotide level in the
bottom lower panels.
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promoters with more than a 5-fold induction after IL-4
stimulation in Ramos cells and with expression level
>5ppm. Figure 1E shows the result of such a search. In
the hypothetical protein LOC746 gene (NM_014206),
second alternative promoter (red) was selectively
induced, while the expression level of the other down-
stream alternative promoter (blue) remained unchanged.
It should be noted that expression analysis using
microarrays or RT–PCR could miss such promoter-
speciﬁc expression changes depending on the positions
of the designed DNA probes or PCR primers. To the
best of our knowledge, there is no database which
represents diﬀerential usage of each of the promoters
under diﬀerent experimental conditions in a quantitative
manner. Recent studies have suggested such diverse
transcriptional regulations give molecular basis to
produce complex functional network of human genes by
a limited number of total genes (7–9). Also, precise iden-
tiﬁcation of the changes in gene expression associated to
each alternative promoter is essential to interpret
accumulating ChIP-Seq data (11), for example, to attri-
bute transcription induction to proximal binding of a
particular transcription factor. Updated DBTSS will
meet the versatile requirements of the analysis of
transcriptional network of human genes in the next gen-
eration sequencing era.
TSS information for non-coding RNAs
The TSS information collected in an unbiased-manner
throughout the human genome is also useful to identify
and characterize hitherto unidentiﬁed transcripts.
Particularly, the new version of DBTSS can be a unique
and important resource for identifying primary transcripts
of miRNAs and other non-coding RNAs (ncRNAs) which
are located in intergenic regions (12). Although hundreds
of putative ncRNAs have been identiﬁed and their biolog-
ical characterization undertaken, there have been only few
cases in which the TSSs of the primary transcripts the
ncRNAs were identiﬁed and their promoter structures
were elucidated. The new DBTSS contains information
of the miRBase database (13) and NR transcript informa-
tion of the RefSeq database (14), and TSSs within an
arbitrary deﬁned distance from the ncRNAs can be
retrieved. As shown in Figure 2A, a possible TSS of a
primary transcript of an miRBase miRNA miR9-2
(miRBase id=MI0000467; http://microrna.sanger.ac
.uk/cgi-bin/sequences/mirna_entry.pl?acc=MI0000467)
Figure 1. Continued.
Nucleic Acids Research, 2010,Vol.38, Database issue D101Figure 2. Interface of the updated ‘ncRNA viewer’ and ‘Comparative Genomic viewer’. (A) Example of the TSS tags identiﬁed from the surround-
ing regions of reported small RNAs. The result of the search for a small ncRNA, miR9-2, is shown. Complete cDNA (AK091356) identiﬁed
in the same region is also represented by orange boxes. (B) Evolutional conservation of the alternative promoters of the protein kinase
C zeta (PRKCZ) genes (NM_002744). Diﬀerent alternative promoters are marked by diﬀerent colors. Upper and lower panels represent the
TSS information in humans and mice, respectively. Corresponding genomic sequences were aligned according to the UCSC Genome Browser
information.
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In addition, our cDNA sequence data also suggested
that this miRNA exists in the 30-end terminal region of a
putative non-coding transcript, AK091356.
Updated comparative genomics viewer
Although DBTSS now includes an unprecedented amount
of data, we were concerned that many promoters
and ncRNAs could be products of ‘transcription noise’,
which might occur in the human genome, and thus
have no biological relevance. In order to address this
concern, we updated our comparative genomic viewer
so that the users can examine the evolutional conservation
of the surrounding genomic sequences and the TSS tag
information against other mammals. Figure 2B
exempliﬁes the case in the protein kinase C zeta
(PRKCZ) gene (NM_002744). This gene contains at
least three alternative promoters as highlighted in blue,
red and green. The most upstream and the third
promoters (blue and green) are used in fetal kidney and
heart, while the second promoter (red) is selectively
used in fetal brain. The genomic sequence of the ﬁrst
two promoters (blue and red) are well-conserved
between human and mouse and corresponding TSS tags
were observed in both species. In contrast, the
genomic sequence surrounding the third promoter
(green) is not conserved, and this promoter does not
seem to be used in mouse. In order to delineate complex
transcriptional regulations of this gene, it is essential to
consider diﬀerent usage and diﬀerent level of the
evolutional conservation of each of the promoters as rep-
resented here.
Similarly, we examined evolutionary conservation of
the intergenic TSCs of >5ppm and found that at least
half are not conserved between human and mouse
(detailed analysis will be published elsewhere). It is still
not clear whether these intergenic clusters of transcription
starts correspond to protein coding or non-coding
RNAs performing human-speciﬁc biological functions or
not. But the information provided in the comparative
display should give useful clues to prioritize the targets
and design future experiments aiming at further functional
studies.
FUTURE PERSPECTIVES
We will continue further updating the next generation
sequencing data for more tissues, cells and experimental
conditions in humans and mice. We have also started col-
lecting similar data from other model organisms, ranging
from various kinds of monocellular eukaryotes, worms,
insects, invertebrates and vertebrates as well. On the
other hand, in order to clarify the biological relevance of
the promoters identiﬁed in DBTSS, we started generating
RNA Seq (15) data using RNA extracted from nuclear,
cytoplasm and translating polysome fractions (16). Such
data will reveal which products are actually translated
into proteins and in which subcellular compartment the
ncRNAs are localized. We believe such integrative
transcriptome data will give users the expanded
knowledge needed for biological interpretation of each
initiation of transcription event.
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